Patents by Inventor Nawaz Khan
Nawaz Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240068690Abstract: A system and method for intelligent operation and control of ductless HVAC devices in a manner similar to existing intelligent operation and control of central HVAC systems. In an embodiment, the system and method comprise using a smart thermostat to separately monitor the room temperature of a room in which a ductless HVAC device is installed, wherein the smart thermostat overrides the standard operation of the HVAC device by setting and re-setting the target temperature of the ductless HVAC device to force it to operate according to settings and algorithms of the smart thermostat which mimic the smart controls available on central HVAC systems.Type: ApplicationFiled: November 3, 2023Publication date: February 29, 2024Inventors: Anees Ahmed Jarral, Waseem Amer, Umair Nawaz Khan, Syeda Farwa Batool, Aftab Farooqi
-
Publication number: 20230314029Abstract: A system and method for a single integrated control solution for ducted and ductless HVAC systems which seamlessly connects the ductless and ducted HVAC units coming from various brands, with no restriction in what brand or HVAC unit the consumers use. The integrated control solution can control all of the units automatically based on settings established or selected by the user, and can be as simple or complex as the user desires.Type: ApplicationFiled: March 30, 2023Publication date: October 5, 2023Inventors: Waseem Amer, Anees Ahmed Jarral, Syeda Farwa Batool, Umair Nawaz Khan, Aftab Farooqi
-
Patent number: 11743946Abstract: The present disclosure relates to methods and arrangements for dynamically configuring repeated transmission of random access response messages from an access node, wherein the random access response message is repeatedly transmitted in response to receipt of a random access request from wireless device operating in a coverage enhancement, CE, mode and wherein the random access response message is configured for repeated transmission on a downlink channel using a repetition level selected from a set of repetition levels associated with a CE level of the CE mode. The repetition level represents a predetermined number of repeated transmissions and the CE level represents a group of wireless devices with similar radio conditions.Type: GrantFiled: October 17, 2017Date of Patent: August 29, 2023Assignee: TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)Inventors: Dino Pjanic, Sergio Almansa-Valverde, Gabriel Cercel, Waqas Nawaz Khan, André Nyberg, Fredrik Saarnak
-
Patent number: 11737159Abstract: A method performed in a network node for identifying UEs which are non-compliant with modified CRS operation. The network node enables CRS operation according to a first configuration for a first period. The network node analyzes Information Elements (IE) in RRC Connection Re-establishment Request messages received from UEs during the first period. The network node generates a first set containing identities of UEs whose values in reestablishmentCause IE in the RRC Connection Re-establishment Request messages received during the first period are “otherFailure”. When the first period is finished, the network node enables CRS operation according a second configuration different from the first configuration for a second period. The network node analyzes IE in RRC Reestablishment Request messages received from UEs during the second period.Type: GrantFiled: October 24, 2018Date of Patent: August 22, 2023Assignee: TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)Inventors: Sergio Almansa-Valverde, Fredrik Saarnak, Waqas Nawaz Khan, Dino Pjanic, Gabriel Cercel, André Nyberg
-
Publication number: 20230261929Abstract: A method and a controller for handling a failure or change of a processing element in a virtual network are provided. The processing element includes a first stateless executable function that use a local state storage and a persistent state storage when executed on a host in the virtual network. The controller maintains the local state storage of the processing element upon removing the first stateless executable function from the processing element in response to the failure or change. The controller also creates a second stateless executable function to replace the first stateless executable function in the processing element. Then, the controller associates the maintained local state storage with the second stateless executable function for the processing element. Further, the controller initiates the second stateless executable function using the associated maintained local state storage such that the processing element resumes execution from its real-time state before the failure or change.Type: ApplicationFiled: June 26, 2020Publication date: August 17, 2023Inventors: Peter ÖHLÉN, Shah Nawaz KHAN, Pedro BATISTA
-
Publication number: 20230115707Abstract: A virtual network function application is to be deployed in a multi-technology virtualization environment. The multi-technology virtualization environment comprises a plurality of virtualization technologies. The application exists in a plurality of application implementations. At least one of the virtualization technologies has a preferred one of the application implementations. The deployment comprises receiving a trigger for a deployment of the virtual network function application. In response to the trigger, information is obtained about at least one optimization objective and about resource utilization in the multi-technology virtualization environment. Based on the received information, one of the plurality of virtualization technologies is selected for said deployment. One of the application implementations is also selected, and the selected application implementation need not be the preferred application implementation for the selected virtualization technology.Type: ApplicationFiled: March 31, 2020Publication date: April 13, 2023Inventor: Shah Nawaz Khan
-
Publication number: 20230022724Abstract: Provided are novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.Type: ApplicationFiled: June 16, 2021Publication date: January 26, 2023Applicant: Hoffmann-La Roche Inc.Inventors: Zhanling CHENG, Nawaz KHAN, Christian KRAMER, Christian LERNER, Philippe PFLIEGER, Theodor STOLL, Jianhua WANG, Yongguang WANG, Song YANG
-
Publication number: 20230017532Abstract: Provided are novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.Type: ApplicationFiled: June 16, 2021Publication date: January 19, 2023Applicant: Hoffmann-La Roche Inc.Inventors: Zhanling CHENG, Nawaz KHAN, Christian KRAMER, Christian LERNER, Matthias NETTEKOVEN, Philippe PFLIEGER, Bernd PUELLMANN, Sebastien SCHMITT, Theodor STOLL, Jianhua WANG, Song YANG
-
Publication number: 20230013602Abstract: Provided are novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R14 are as described herein and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.Type: ApplicationFiled: June 16, 2021Publication date: January 19, 2023Applicant: Hoffmann-La Roche Inc.Inventors: Jean-Baptiste BLANC, Nawaz KHAN, Christian KRAMER, Christian LERNER, Philippe PFLIEGER, Theodor STOLL, Song YANG
-
Publication number: 20230012368Abstract: Provided are novel imidazopyrazine derivatives having the general formula (I), wherein R1 to R11 are as described herein and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.Type: ApplicationFiled: June 16, 2021Publication date: January 12, 2023Applicant: Hoffmann-La Roche Inc.Inventors: Jean-Baptiste BLANC, Zhanling CHENG, Xingchun HAN, Nawaz KHAN, Christian KRAMER, Holger KUEHNE, Christian LERNER, Matthias NETTEKOVEN, Philippe PFLIEGER, Bernd PUELLMANN, Sebastien SCHMITT, Theodor STOLL, Jianhua WANG, Yongguang WANG, Song YANG
-
Publication number: 20230011869Abstract: Provided are novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.Type: ApplicationFiled: June 16, 2021Publication date: January 12, 2023Applicant: Hoffmann-La Roche Inc.Inventors: Zhanling CHENG, Nawaz KHAN, Christian KRAMER, Christian LERNER, Philippe PFLIEGER, Theodor STOLL, Jianhua WANG, Min WANG, Yongguang WANG, Song YANG
-
Publication number: 20220372027Abstract: The invention encompasses a new series of antibacterial compounds, compositions containing these compounds, and methods of treating Enterobacteriaceae bacterial diseases and infections using these compounds. The compounds find application in the treatment of infection with, and disease caused by Gram-negative bacteria Enterobacteriaceae species that have developed resistance to existing antibiotics.Type: ApplicationFiled: April 25, 2022Publication date: November 24, 2022Inventors: Paul Meo, Mohammed Nawaz Khan, Cedric Charrier
-
Patent number: 11345694Abstract: The present invention relates to compounds of general formula (II), to compositions comprising these compounds and to methods of treating Enterobacteriaceae bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Enterobacteriaceae.Type: GrantFiled: November 2, 2018Date of Patent: May 31, 2022Assignee: Discuva Ltd.Inventors: Paul Meo, Mohammed Nawaz Khan, Cedric Charrier
-
Publication number: 20210392715Abstract: A method performed in a network node for identifying UEs which are non-compliant with modified CRS operation. The network node enables CRS operation according to a first configuration for a first period. The network node analyzes Information Elements (IE) in RRC Connection Re-establishment Request messages received from UEs during the first period. The network node generates a first set containing identities of UEs whose values in reestablishmentCause IE in the RRC Connection Re-establishment Request messages received during the first period are “otherFailure”. When the first period is finished, the network node enables CRS operation according a second configuration different from the first configuration for a second period. The network node analyzes IE in RRC Reestablishment Request messages received from UEs during the second period.Type: ApplicationFiled: October 24, 2018Publication date: December 16, 2021Inventors: Sergio Almansa-Valverde, Fredrik Saarnak, Waqas Nawaz Khan, Dino Pjanic, Gabriel Cercel, André Nyberg
-
Patent number: 11096107Abstract: A method is disclosed for a network node of a cellular communication network adapted for application of an uplink triggered cell handover functionality. The uplink triggered cell handover functionality may comprise initiating a handover when it is determined that an uplink channel performance metric relating to a serving cell falls on a first side of (e.g. is lower than) an uplink handover threshold. The method comprises dynamically restricting application of the uplink triggered cell handover functionality based on whether a restriction criterion is met or not. The restriction criterion is based on at least one of a resource cost of the uplink triggered cell handover functionality and a performance gain of the uplink triggered cell handover functionality.Type: GrantFiled: April 11, 2017Date of Patent: August 17, 2021Assignee: Telefonaktiebolaget LM Ericsson (publ)Inventors: Joachim Ramkull, Mariell Eriksen, Waqas Nawaz Khan, Ingvar Pålsson
-
Publication number: 20210163460Abstract: The present invention relates to compounds of general formula (II), to compositions comprising these compounds and to methods of treating Enterobacteriaceae bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Enterobacteriaceae.Type: ApplicationFiled: November 2, 2018Publication date: June 3, 2021Applicant: DISCUVA LTD.Inventors: Paul MEO, Mohammed Nawaz KHAN, Cedric CHARRIER
-
Publication number: 20210014762Abstract: A method is disclosed for a network node of a cellular communication network adapted for application of an uplink triggered cell handover functionality. The uplink triggered cell handover functionality may comprise initiating a handover when it is determined that an uplink channel performance metric relating to a serving cell falls on a first side of (e.g. is lower than) an uplink handover threshold. The method comprises dynamically restricting application of the uplink triggered cell handover functionality based on whether a restriction criterion is met or not. The restriction criterion is based on at least one of a resource cost of the uplink triggered cell handover functionality and a performance gain of the uplink triggered cell handover functionality.Type: ApplicationFiled: April 11, 2017Publication date: January 14, 2021Inventors: Joachim Ramkull, Mariell Eriksen, Waqas Nawaz Khan, Ingvar Pålsson
-
Publication number: 20200221502Abstract: The present disclosure relates to methods and arrangements for dynamically configuring repeated transmission of random access response messages from an access node, wherein the random access response message is repeatedly transmitted in response to receipt of a random access request from wireless device operating in a coverage enhancement, CE, mode and wherein the random access response message is configured for repeated transmission on a downlink channel using a repetition level selected from a set of repetition levels associated with a CE level of the CE mode. The repetition level represents a predetermined number of repeated transmissions and the CE level represents a group of wireless devices with similar radio conditions.Type: ApplicationFiled: October 17, 2017Publication date: July 9, 2020Inventors: Dino Pjanic, Sergio Almansa-Valverde, Gabriel Cercel, Waqas Nawaz Khan, André Nyberg, Fredrik Saarnak
-
Publication number: 20190194179Abstract: The present invention relates to antibiotic compounds of formula (I), to compositions containing these compounds and to methods of treating bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Gram-positive and/or Gram-negative bacteria, and in particular in the treatment of infection with, and diseases caused by, Neisseria gonorrhoeae.Type: ApplicationFiled: August 22, 2017Publication date: June 27, 2019Applicant: DISCUVA LTD.Inventors: Paul MEO, Nawaz KHAN
-
Patent number: 9675567Abstract: Compounds of formula (I): and pharmacologically acceptable salts and pro-drugs thereof, wherein the variables are as defined in the specification, are potassium ion channel modulators, making them particularly useful in treating and preventing conditions such as pain, lower urinary tract disorders and the like.Type: GrantFiled: September 8, 2016Date of Patent: June 13, 2017Assignee: Ramot at Tel-Aviv University Ltd.Inventors: Simon Edwards, Ruth Meriel Kimberley, Richard Edward Armer, Mohammed Nawaz Khan